Cargando…

[(68)Ga]Ga-NODAGA-E[(cRGDyK)](2) PET and hyperpolarized [1-(13)C] pyruvate MRSI (hyperPET) in canine cancer patients: simultaneous imaging of angiogenesis and the Warburg effect

PURPOSE: Cancer has a multitude of phenotypic expressions and identifying these are important for correct diagnosis and treatment selection. Clinical molecular imaging such as positron emission tomography can access several of these hallmarks of cancer non-invasively. Recently, hyperpolarized magnet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clemmensen, Andreas, Hansen, Adam E, Holst, Pernille, Schøier, Christina, Bisgaard, Sissel, Johannesen, Helle H, Ardenkjær-Larsen, Jan Henrik, Kristensen, Annemarie T, Kjaer, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835292/ https://www.ncbi.nlm.nih.gov/pubmed/32621132 http://dx.doi.org/10.1007/s00259-020-04881-0

Ejemplares similares

[(68)Ga]Ga-NODAGA-E[(cRGDyK)](2) Angiogenesis PET/MR in a Porcine Model of Chronic Myocardial Infarction
por: Bentsen, Simon, et al.
Publicado: (2021)

[(68)Ga]Ga-NODAGA-E[(cRGDyK)](2) and [(64)Cu]Cu-DOTATATE PET Predict Improvement in Ischemic Cardiomyopathy
por: Follin, Bjarke, et al.
Publicado: (2023)

Angiogenesis PET Tracer Uptake ((68)Ga-NODAGA-E[(cRGDyK)](2)) in Induced Myocardial Infarction in Minipigs
por: Rasmussen, Thomas, et al.
Publicado: (2016)

[(68)Ga]Ga-NODAGA-E[(cRGDyK)](2) angiogenesis PET following myocardial infarction in an experimental rat model predicts cardiac functional parameters and development of heart failure
por: Bentsen, Simon, et al.
Publicado: (2023)

Angiogenesis PET Tracer Uptake ((68)Ga-NODAGA-E[(cRGDyK)](2)) in Induced Myocardial Infarction and Stromal Cell Treatment in Minipigs
por: Rasmussen, Thomas, et al.
Publicado: (2018)

First in-human radiation dosimetry of (68)Ga-NODAGA-RGDyK
por: Gnesin, Silvano, et al.
Publicado: (2017)

Simultaneous PET/MRI with (13)C magnetic resonance spectroscopic imaging (hyperPET): phantom-based evaluation of PET quantification
por: Hansen, Adam E., et al.
Publicado: (2016)

In Vivo Phenotyping of Tumor Metabolism in a Canine Cancer Patient with Simultaneous (18)F-FDG-PET and Hyperpolarized (13)C-Pyruvate Magnetic Resonance Spectroscopic Imaging (hyperPET): Mismatch Demonstrates that FDG may not Always Reflect the Warburg Effect
por: Gutte, Henrik, et al.
Publicado: (2015)

First-in-Human Study of [(68)Ga]Ga-NODAGA-E[c(RGDyK)](2) PET for Integrin α(v)β(3) Imaging in Patients with Breast Cancer and Neuroendocrine Neoplasms: Safety, Dosimetry and Tumor Imaging Ability
por: Clausen, Malene Martini, et al.
Publicado: (2022)

Evaluation of [(68)Ga]Ga-NODAGA-RGD for PET Imaging of Rat Autoimmune Myocarditis
por: Jahandideh, Arghavan, et al.
Publicado: (2021)

Simultaneous characterization of tumor cellularity and the Warburg effect with PET, MRI and hyperpolarized (13)C-MRSI
por: Hundshammer, Christian, et al.
Publicado: (2018)

In Vitro/In Vivo Preparation and Evaluation of cRGDyK Peptide-Modified Polydopamine-Bridged Paclitaxel-Loaded Nanoparticles
por: Yun, Dan, et al.
Publicado: (2023)

PET Probes for Preclinical Imaging of GRPR-Positive Prostate Cancer: Comparative Preclinical Study of [(68)Ga]Ga-NODAGA-AMBA and [(44)Sc]Sc-NODAGA-AMBA
por: Kálmán-Szabó, Ibolya, et al.
Publicado: (2022)

Association between [(68)Ga]NODAGA-RGDyK uptake and dynamics of angiogenesis in a human cell-based 3D model
por: Grönman, Maria, et al.
Publicado: (2021)

Preparation, Characterization, and Radiolabeling of [(68)Ga]Ga-NODAGA-Pamidronic Acid: A Potential PET Bone Imaging Agent
por: Ashhar, Zarif, et al.
Publicado: (2020)

(68)Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism
por: Boss, Marti, et al.
Publicado: (2022)

[(68)Ga]Ga-DFO-c(RGDyK): Synthesis and Evaluation of Its Potential for Tumor Imaging in Mice
por: Krajcovicova, Sona, et al.
Publicado: (2021)

Brain Imaging of the GLP-1 Receptor in Obesity Using (68)Ga-NODAGA-Exendin-4 PET
por: Deden, Laura N., et al.
Publicado: (2021)

cRGDyK-modified procaine liposome inhibits the proliferation and motility of glioma cells via the ERK/p38MAPK pathway
por: Li, Dedong, et al.
Publicado: (2021)

PET-Based Human Dosimetry of (68)Ga-NODAGA-Exendin-4, a Tracer for β-Cell Imaging
por: Boss, Marti, et al.
Publicado: (2020)

(64)Cu-NODAGA-c(RGDyK) Is a Promising New Angiogenesis PET Tracer: Correlation between Tumor Uptake and Integrin α (V) β (3) Expression in Human Neuroendocrine Tumor Xenografts
por: Oxboel, Jytte, et al.
Publicado: (2012)

PET imaging of (68)Ga-NODAGA-RGD, as compared with (18)F-fluorodeoxyglucose, in experimental rodent models of engrafted glioblastoma
por: Isal, Sibel, et al.
Publicado: (2018)

Imaging angiogenesis in atherosclerosis in large arteries with (68)Ga-NODAGA-RGD PET/CT: relationship with clinical atherosclerotic cardiovascular disease
por: Dietz, Matthieu, et al.
Publicado: (2021)

Development of a Symmetric Echo-Planar Spectroscopy Imaging Framework for Hyperpolarized (13)C Imaging in a Clinical PET/MR Scanner
por: Eldirdiri, Abubakr, et al.
Publicado: (2018)

Synthesis of Novel, Dual-Targeting (68)Ga-NODAGA-LacN-E[c(RGDfK)](2) Glycopeptide as a PET Imaging Agent for Cancer Diagnosis
por: Gyuricza, Barbara, et al.
Publicado: (2021)

Head and neck tumors angiogenesis imaging with (68)Ga-NODAGA-RGD in comparison to (18)F-FDG PET/CT: a pilot study
por: Durante, Steve, et al.
Publicado: (2020)

PET imaging of an optimized anti-PD-L1 probe (68)Ga-NODAGA-BMS986192 in immunocompetent mice and non-human primates
por: Zhou, Huimin, et al.
Publicado: (2022)

The Role of Glucagon-Like Peptide 1 Receptor PET/CT With Ga-68-NODAGA-exendin in Localising an Insulinoma: Lessons From a Clinical Case
por: Grigoriadou, Viktoria Chatzimavridou, et al.
Publicado: (2021)

Comparison of Ga-68-Labeled Fusarinine C-Based Multivalent RGD Conjugates and [(68)Ga]NODAGA-RGD—In Vivo Imaging Studies in Human Xenograft Tumors
por: Zhai, Chuangyan, et al.
Publicado: (2016)

Congruency of tumour volume delineated by FET PET and MRSI
por: Mauler, Jörg, et al.
Publicado: (2015)

Accuracy of PET quantification in [(68)Ga]Ga-pentixafor PET/MR imaging of carotid plaques
por: Rausch, Ivo, et al.
Publicado: (2020)

Comparison of integrin α(v)β(3) expression with (68)Ga-NODAGA-RGD PET/CT and glucose metabolism with (18)F-FDG PET/CT in esophageal or gastroesophageal junction cancers
por: Dietz, Matthieu, et al.
Publicado: (2023)

The Role of [(68)Ga]Ga-Pentixafor PET/CT or PET/MRI in Lymphoma: A Systematic Review
por: Albano, Domenico, et al.
Publicado: (2022)

Intra-individual qualitative and quantitative comparison of [(68)Ga]Ga-DOTATATE PET/CT and PET/MRI
por: Lens, Géraldine, et al.
Publicado: (2023)

Voxel-based comparison of [(68)Ga]Ga-RM2-PET/CT and [(68)Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer
por: Fassbender, Thomas Franz, et al.
Publicado: (2020)

Fully automated radiolabeling of [(68)Ga]Ga-EMP100 targeting c-MET for PET-CT clinical imaging
por: Rusu, Timofei, et al.
Publicado: (2023)

[(68)Ga]Ga-DOTA-TOC: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging
por: Hennrich, Ute, et al.
Publicado: (2020)

In Vivo Imaging of Experimental Melanoma Tumors using the Novel Radiotracer (68)Ga-NODAGA-Procainamide (PCA)
por: Kertész, István, et al.
Publicado: (2017)

Human Dose Assessment of (68)Ga-NODAGA-RGD-BBN Heterodimer Peptide based on Animal Data
por: Amraee, Naeimeh, et al.
Publicado: (2022)

Prospective data-driven respiratory gating of [(68)Ga]Ga-DOTATOC PET/CT
por: Sigfridsson, Jonathan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p8s97210oqm4eguvl8joji7ing